API CBD Isolate
Product Description
Averix Bio
-
US
-
2022On CPHI since
-
3Certificates
-
25 - 49Employees
Company types
Primary activities
Categories
Specifications
Averix Bio
-
US
-
2022On CPHI since
-
3Certificates
-
25 - 49Employees
Company types
Primary activities
Averix Bio resources (1)
-
News Averix Bio announces submission of drug master file for cannabidiol API (CBD) Isolate
Averix Bio announces its submission of a Drug Master File (DMF) to the US Food & Drug Administration (FDA) for cannabidiol (CBD) isolate.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance